GLP-1 Weight Loss Treatment
in New York, NY

Injectable tirzepatide is $219 per month. Pricing includes provider review, prescription if approved, shipping included if prescribed, and ongoing support. No membership fees. Pricing and availability are subject to clinical appropriateness and regulatory change. No insurance required.

In most cases, no. Open Water Rx is a telehealth service. Your evaluation, provider review, prescription, and ongoing support all happen online. Some states require a synchronous initial visit. Available nationwide in all 50 states.

Provider review timelines vary. Once approved, your medication ships from a licensed pharmacy. Delivery timelines vary by pharmacy and location. Available nationwide in all 50 states.

Through Open Water Rx, independent licensed medical providers may prescribe compounded semaglutide and compounded tirzepatide when clinically appropriate for eligible New York patients. Wegovy® and Ozempic® are FDA-approved brand-name medicines containing semaglutide; Zepbound® and Mounjaro® are FDA-approved brand-name medicines containing tirzepatide. Your provider will recommend the best option based on your health profile.

Compounded semaglutide and tirzepatide are prescribed when an independent, licensed medical provider determines it is clinically appropriate for the individual patient, for example, when a patient requires a specific dosage strength, formulation, or delivery method not available in the commercially manufactured product, or when the patient has a documented clinical need the branded product cannot meet.

Compounding is not offered simply as a lower-cost alternative to Wegovy®, Ozempic®, Zepbound®, or Mounjaro®. Under FDA regulations, compounding is only legally permissible when there is a valid individual clinical reason. Your prescribing provider makes this determination independently, based solely on your health profile, not on cost or convenience.

They are prepared by independent, licensed compounding pharmacies operating under Section 503A of the Federal Food, Drug, and Cosmetic Act. Open Water Rx does not manufacture, compound, or dispense medications.

Both semaglutide and tirzepatide are GLP-1 receptor agonists available to eligible New York patients through Open Water Rx. Semaglutide activates a single GLP-1 receptor pathway. Tirzepatide is a dual GIP/GLP-1 receptor agonist that activates two pathways simultaneously, which may produce greater appetite suppression.

Your licensed medical provider will recommend the most appropriate option based on your individual health profile, goals, and clinical history. Individual results vary and are not guaranteed.

Semaglutide plans are $169/month. Injectable tirzepatide is $219/month for eligible patients. Provider review, medication if prescribed, and shipping if prescribed all included. No insurance required.

Both brands are operated by Open Water Rx LLC. Surfbound Health is our current brand for online enrollment; this site provides program, pricing and support information.

Yes. Open Water Rx is a telehealth platform that facilitates access to clinician-reviewed GLP-1 weight loss programs for eligible New York residents. After a short online health evaluation, an independent licensed medical provider reviews your case. If compounded semaglutide is clinically appropriate, a prescription may be issued and medication shipped discreetly to your New York address. Shipping is included in your plan price.

Yes. Eligible New York residents can explore compounded tirzepatide as a GLP-1 weight loss option through Open Water Rx's telehealth platform. Tirzepatide is a dual GIP/GLP-1 receptor agonist that activates two appetite-signaling pathways simultaneously. Clinical trial data with FDA-approved tirzepatide formulations suggests this may produce greater weight reduction than semaglutide alone in some patients. If your licensed provider determines tirzepatide is appropriate, medication is shipped discreetly to your New York address if prescribed.

Open Water Rx does not dispense brand-name Wegovy®, Ozempic®, Zepbound®, or Mounjaro®. Open Water Rx is a telehealth platform that facilitates access to clinician-reviewed pathways that may include compounded semaglutide or compounded tirzepatide, prepared by independent, licensed compounding pharmacies, when those options are legally available and clinically appropriate for the individual patient.

Compounded medications are not FDA-approved finished drug products and are not generic versions of any brand-name drug. If a brand-name GLP-1 medication is more appropriate for your clinical needs, your provider will advise you accordingly.

Yes. New York patients access Open Water Rx entirely online: no clinic, no waiting room, no in-person visit required in most cases. The process: (1) Complete a 5-minute online health evaluation. (2) An independent licensed medical provider reviews your intake. (3) If a GLP-1 medication pathway is clinically appropriate, a prescription is issued. (4) Medication is prepared by a licensed compounding pharmacy and shipped discreetly to your New York address, with shipping included in your plan price. (5) Ongoing clinician support is included throughout your program. Available nationwide in all 50 states. Some states require a synchronous initial telehealth visit before prescribing.

Injectable tirzepatide is $219/month for eligible New York patients. Semaglutide programs are $169/month. Each plan includes the licensed provider review, prescription if clinically approved, medication preparation, and discreet shipping to your New York address if prescribed. No insurance is required or accepted. HSA/FSA funds may be applicable. Check with your plan administrator. Pricing is subject to change and clinical appropriateness.

Yes. Open Water Rx serves eligible patients across all five boroughs entirely online. You complete the secure intake from home, an independent New York-licensed provider reviews your case, and if clinically appropriate the medication ships discreetly to your address.

Compounded injectable semaglutide is $169/month and compounded tirzepatide is $219/month, billed flat month to month with no membership fee and no separate provider fee. Provider review, the medication if prescribed, and shipping if prescribed are included.

No. The program is self-pay and works without insurance, so there is no prior authorization to wait on. HSA and FSA funds may apply.

Yes. Note your current semaglutide or tirzepatide dose and whether you want to keep or increase it in the doctor-notes field at signup. We can match your dose when clinically appropriate; the prescribing provider decides.

One flat monthly price with no membership fee, care that is entirely online — no subway ride to a clinic — and discreet delivery if prescribed, with independent New York-licensed providers making every clinical decision.